Topiramate for the Treatment of Methamphetamine Dependence - 1
Public ClinicalTrials.gov record NCT00345371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Double-Blind, Placebo-Controlled Trial of Topiramate for the Treatment of Methamphetamine Dependence
Study identification
- NCT ID
- NCT00345371
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Interventions
- Topiramate Drug
- Placebo Oral Tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2006
- Primary completion
- Jul 31, 2008
- Completion
- Nov 30, 2008
- Last update posted
- Mar 26, 2017
2006 – 2008
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Matrix Institute on Addictions | Costa Mesa | California | 92627 | — |
| South Bay Treatment Center | San Diego | California | 92105 | — |
| Torrance Site | Torrance | California | 90502 | — |
| John A. Burns School of Medicine | Honolulu | Hawaii | 96813 | — |
| Powell Chemical Dependency Center | Des Moines | Iowa | 50316 | — |
| University of Missouri - Kansas City | Kansas City | Missouri | 64108 | — |
| Salt Lake City VA Medical Center | Salt Lake City | Utah | 84148 | — |
| UVA CARE | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00345371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00345371 live on ClinicalTrials.gov.